Publication | Open Access

Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets

ThrombopoiesisThrombosisMedicinal ChemistryBiochemistryBlood PlateletMedicineNatural SciencesPharmacotherapySyk-selective InhibitorPlatelet AntagonistPharmacologyAnticoagulantPharmaceutical ChemistryDrug Discovery